Affinium Pharmaceuticals Ltd.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.afnm.com
A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
Phase 2
Completed
- Conditions
- Skin and Subcutaneous Tissue Bacterial InfectionsWound InfectionCutaneous AbscessBurn InfectionCellulitis
- Interventions
- First Posted Date
- 2012-01-27
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Affinium Pharmaceuticals, Ltd
- Target Recruit Count
- 103
- Registration Number
- NCT01519492
- Locations
- 🇺🇸
SITE 017, Augusta, Georgia, United States
🇨🇦SITE 015, Kingston, Ontario, Canada
🇺🇸SITE 004, Savannah, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath